"Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing" was originally created and published by Medical ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics ...

Formed in 2019, Sionna's most recent financing was a $182 million third round that closed last year, which followed a $111 ...

Technology & Telecommunication Acquisition Corp (NASDAQ:TETE), a special purpose acquisition company, has been notified of its pending delisting from the Nasdaq Stock Market due to non-compliance with ...

The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...

Nasdaq CEO Adena Friedman is optimistic that President Trump's administration will offer a chance to relook regulations in ...

Spirit Advisors LLC proudly announces the successful completion of the initial public offering (IPO) of PicoCELA Inc. (Nasdaq ...

Skadden, Latham, Kirkland and Davis Polk—traditionally the strongest legal advisers for major U.S. listings by Chinese companies—acted on fewer than five of these IPOs last year, according to a ...

According to Nasdaq’s data, the U.S. saw 179 non-SPAC IPOs in 2024 ... A “fairer” comparison is to look at the percentage increase in listings due to IPOs in each country. We show that in the grey ...

Aardvark said it applied to list on the Nasdaq Global Market under the symbol AARD. The company didn't give an expected size for its IPO, nor did it offer an expected price range. Morgan Stanley, B of ...

TOKYO and NEW YORK, Jan. 20, 2025 /PRNewswire/ -- Spirit Advisors LLC proudly announces the successful completion of the initial public offering (IPO) of PicoCELA Inc. (Nasdaq: PCLA), a pioneer in ...

Nasdaq Chair and CEO Adena Friedman sees 2025 as a constructive year for new issuance and IPOs and discusses regulatory ...